共 50 条
- [13] Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (07): : 609 - 611
- [20] Daratumumab (anti-CD38) induces loss of CD38 on red blood cells BLOOD, 2017, 129 (22) : 3033 - 3037